The role of mast cells in allergic rhinitis

Jin Zhang, Xiaofei Xie, Ruixia Ma, Peng LiuPeerJ 2025 · DOI

TL;DR

This review synthesizes current knowledge on the critical role of mast cells (MCs) in allergic rhinitis (AR), a prevalent inflammatory nasal condition. It highlights how MCs, through the release of various mediators, orchestrate both the immediate and delayed phases of AR, and explores the complex signaling pathways that govern their activation, offering insights for future therapeutic strategies.

What Problem Does This Paper Address?

Allergic rhinitis (AR) is a widespread and impactful chronic nasal disease affecting millions globally, significantly impacting quality of life. While mast cells (MCs) have long been recognized as key players in AR pathogenesis, a comprehensive understanding of their intricate roles, from development and activation to mediator release and their interplay with other immune cells, remains incomplete. Specifically, the precise mechanisms governing the recruitment and activation of MC progenitor cells in the nasal mucosa, and the full spectrum of signaling pathways involved in MC activation, require further elucidation. This review aims to bridge these knowledge gaps by providing an up-to-date synthesis of the literature, essential for developing more effective AR treatments.

Methods

This paper is a literature review. The authors conducted a thorough search of PubMed and China National Knowledge Infrastructure (CNKI) databases, focusing on recent studies (within the last decade) related to mast cells and allergic rhinitis. They employed keywords such as "mast cells," "allergic rhinitis," "mast cell progenitor cells," "activation pathways," and "pathogenesis," with no time limit on the search. The retrieved articles were critically evaluated for quality and relevance, and cross-referenced to identify gaps and inconsistencies in the existing literature.

Datasets

Not discussed in the paper. This is a literature review, not an experimental study that relies on specific datasets.

Key Insights and Ideas

  • MCs are central orchestrators of AR: Beyond just releasing histamine, MCs are pivotal in initiating and sustaining the inflammatory cascade in AR, influencing both early and late-phase reactions.
  • Dual role of MCs: While crucial for immune defense against pathogens and parasites, MCs can also contribute to detrimental inflammatory states like AR when dysregulated.
  • Complex activation pathways: MC activation isn't solely IgE-dependent. A variety of receptors, including Toll-like receptors (TLRs) and complement receptors, can trigger MCs, highlighting their multifaceted responsiveness.
  • Heterogeneity of MCs: MCs are not a monolithic population. Their heterogeneity, influenced by microenvironmental factors, means they can exhibit tissue-specific functions and receptor expression patterns.
  • Early life programming: Emerging research suggests MCs play a role in shaping immune susceptibility early in life, potentially laying the foundation for allergic responses.
  • Therapeutic targets: Understanding the specific signaling pathways (e.g., Lyn-Syk, Fyn-dependent pathways, TLRs, CCR3) involved in MC activation opens avenues for targeted therapies beyond traditional antihistamines.

Key Results

This review synthesizes findings from numerous studies, rather than presenting novel experimental results. Key "results" are the consolidated understanding of:

  • Early Phase Reaction: MCs rapidly release preformed mediators like histamine upon allergen exposure, leading to itching, sneezing, and increased vascular permeability within minutes.
  • Late Phase Reaction: Following the initial release, MCs further secrete cytokines and chemokines, attracting inflammatory cells (eosinophils, neutrophils, Th2 cells) that sustain inflammation for up to 24 hours.
  • Signaling Pathway Involvement: The review details how IgE cross-linking of FcεRI activates Lyn and Syk kinases, leading to downstream signaling that drives MC degranulation. It also highlights the roles of Fyn, C-Kit, complement receptors (C3aR, C5aR), TLRs, and CCR3 in MC activation.
  • Therapeutic Implications: The paper points to the potential of targeting specific signaling molecules (e.g., Lyn, Syk, CCR3) or receptors (e.g., TLRs) for AR treatment, with some studies showing promising results with compounds like dasatinib and alpha-linolenic acid.

Limitations and Future Work

The authors acknowledge that despite substantial progress, several critical gaps remain in understanding the complex interplay between MCs, their mediators, and the broader immune system in AR. The specific mechanisms underlying the recruitment and activation of MC progenitor cells in the nasal mucosa are still poorly understood. Future research should focus on elucidating these mechanisms to develop more effective therapeutic strategies. The review also implicitly suggests that further investigation into the non-immunological activation pathways of MCs and the therapeutic potential of targeting these pathways is warranted.

Summary updated

Abstract

This review is intended for a broad audience, including researchers in the fields of immunology, allergy, and respiratory medicine, as well as clinicians who manage patients with allergic rhinitis. By summarizing the latest findings and highlighting the unresolved questions, this review aims to serve as a valuable reference for future research directions in mast cells and allergic rhinitis, ultimately contributing to improved patient care and outcomes.
BibTeX
@inproceedings{zhang2025role,
  author = {Jin Zhang and Xiaofei Xie and Ruixia Ma and Peng Liu},
  title = {{The role of mast cells in allergic rhinitis}},
  booktitle = {PeerJ},
  year = {2025},
  doi = {10.7717/peerj.19734},
}
Figure